Identification of myeloid-derived suppressor cells and T regulatory cells in lung microenvironment after urethane-induced lung tumor

International Immunopharmacology

Volumn 11, Issue 7, 2011, Pages 873-878

  Rosin, Flávia Cristina Perillo ^a   Pedregosa, Juliana Figueredo ^a   De Almeida, Joaquim Soares ^a   Bueno, Valquiria ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Flow cytometry; IFN gamma; Lung cancer; Myeloid suppressor cells; Regulatory T cells; Urethane

Indexed keywords

GAMMA INTERFERON; NITRIC OXIDE; NITRITE; TRANSCRIPTION FACTOR FOXP3; URETHAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; BONE MARROW CELL; CONTROLLED STUDY; EX VIVO STUDY; FLOW CYTOMETRY; HISTOPATHOLOGY; LUNG; LUNG NODULE; LUNG TUMOR; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SPLEEN; SPLEEN CELL; SUPPRESSOR CELL; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

EID: 79958038501     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2010.12.025     Document Type: Article

References (23)

1. Malkinson AM. Molecular comparison of human and mouse pulmonary adenocarcinomas. Exp Lung Res 1998;24:541-55. (Pubitemid 28308950)
2. Karasaki H, Obata M, Ogawa K, Lee GH. Roles of the Pas1 and Par2 genes in determination of the unique, intermediate susceptibility of BALB/cByJ mice to urethane-induction of lung carcinogenesis: differential effects on tumor multiplicity, size and Kras2 mutations. Oncogene 1997;15:1833-40. (Pubitemid 27478626)
3. Salinas NR, Lopes CT, Palma PV, Oshima CT, Bueno V. Lung tumor development in the presence of sphingosine 1-phosphate agonist FTY720. Pathol Oncol Res 2009;15:549-54.
4. Salinas NR, Oshima CT, Cury PM, Cordeiro JA, Bueno V. FTY720 and lung tumor development. Int Immunopharmacol 2009;9(6):689-93.
5. Redente EF, Dwyer-Nield LD, Barrett BS, Riches DW, Malkinson AM. Lung tumor growth is stimulated in IFN-gamma-/- nice and inhibited in IL-4Ralpha-/- mice. Anticancer Res 2009;29(12):5095-101.
6. Ohshima H, Bartsch H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat Res 1994;305(2):253-64. (Pubitemid 24082901)
7. Liu RH, Hotchkiss JH. Potential genotoxicity of chronically elevated nitric oxide: a review. Mutat Res 1995;339(2):73-89.
8. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15 N] nitrate in biological fluids. Anal Biochem 1982;126(1):131-8. (Pubitemid 13203451)
9. Colakogullari M, Ulukava E, Yilmaztepe A, Ocakoglu G, Yilmaz M, Karadag M, et al. Higher serum nitrate levels are associated with poor survival in lung cancer patients. Clin Biochem 2006;38:898-903. (Pubitemid 44344692)
10. Watanabe S, Deguchi K, Zheng R, Tamai H, Wang L, Cohen PA, et al. Tumor-induced CD11bGr-1 myeloid cells suppress T cell sensitization in tumor-draining lymph nodes. J Immunol 2008;181:3291-300.
11. Gabrilovich DI, Velders MP, Sotomayor EM, Kast WM. Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells. J Immunol 2001;166:5398-406. (Pubitemid 32374159)
12. + regulatory T cells in K-Ras-driven lung tumorigenesis. PLoS ONE 2009;4(3):e5061.
13. Jia W, Jackson-Cook C, Graf MR. Tumor-infiltrating, myeloide-derived suppressor cells inhibit T cell activity by nitric oxide production in an intracranial rat glioma +vaccination model. J Neuroimmunol 2010;223:20-30.
14. Silva LBL, Ribeiro DA, Cury PM, Cordeiro JA, Bueno V. FTY720 treatment in experimentally urethane-induced lung tumors. J Exp Ther Oncol 2008;7:9-15.
15. Bauer AK, Dwyer-Nield LD, Malkinson AM. High cyclooxygenase 1 (COX-1) and cyclooxygenase 2 (COX-2) contents in mouse lung tumors. Carcinogenesis 2000;21(4):543-50. (Pubitemid 30214004)
16. Jenkins DC, Charles IG, Thomsen LL. Roles of nitric oxide in tumor growth. Proc Natl Acad Sci USA 1995;92(10):4392-6.
17. Wink DA, Vodovotz Y, Laval J, Laval F, Dewhirst MW, Mitchell JB. The multifaceted roles of nitric oxide in cancer. Carcinogenesis 1998;19(5):711-21. (Pubitemid 28376759)
18. Kaynar H, Meral M, Turhan H, Keles M, Celik G, Akcay F. Glutathione peroxidase, glutathione-S-transferase, catalase, xanthine oxidase, Cu-Zn superoxide dismutase activities, total glutathione, nitric oxide, and malondialdehyde levels in erythrocytes of patients with small cell and non-small cell lung cancer. Cancer Lett 2005;227(2):133-9. (Pubitemid 41169926)
19. int immature myeloid cells in tumor-bearing mice. Microbiol Immunol 2008;52:47-53.
20. Liu C, Yu S, Kappes J, Wang J, Grizzle WE, Zinn KR, et al. Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host. Blood 2007;109(10):4336-42. (Pubitemid 46743401)
21. Karanikas V, Speletas M, Zamanakou M, Kalala F, Loules G, Kerenidi T, et al. Foxp3 expression in human cancer cells. J Transl Med 2008;6:19, doi:10.1186/1479-5876-6-19.
22. Ishibashi Y, Tanaka S, Tajima K, Yoshida T, Kuwano H. Expression of Foxp3 in non-small cell lung cancer patients is significantly higher in tumor tissues than in normal tissues, especially in tumors smaller than 30 mm. Oncol Rep 2006;15:1315-9.
23. Satoh H, Moriguchi T, Taguchi K, Takai J, Maher JM, Suzuki T, et al. Nrf2-deficienty creates a responsive microenvironment for metastasis to the lung. Carcinogenesis 2010;31(10):1833-43.